الصفحة الرئيسية>>Signaling Pathways>> Others>>NIH-12848

NIH-12848

رقم الكتالوجGC32465

المعاهد الوطنية للصحة -12848 مثبطات فوسفاتيديلينوسيتول 5-فوسفات 4-كيناز γ (PI5P4Kγ) مفترضة مع IC 50 من 1 ميكرومتر

Products are for research use only. Not for human use. We do not sell to patients.

NIH-12848 التركيب الكيميائي

Cas No.: 959551-10-1

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
91٫00
متوفر
5mg
82٫00
متوفر
10mg
115٫00
متوفر
50mg
414٫00
متوفر
100mg
689٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

NIH-12848 is a putative phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) inhibitor with an IC50 of 1 μM.

NIH-12848 inhibits PI5P4Kγ with an IC50 of approximately 1 μM but does not inhibit the α and β PI5P4K isoforms at concentrations up to 100 μM. NIH-12848 inhibits the translocation of Na+/ K+-ATPase to the plasma membrane that occurs when mpkCCD cells grow to confluence and also prevents reversibly their forming of 'domes' on the culture dish. Both these NIH-12848-induced effects are mimicked by specific RNAi knockdown of PI5P4Kγ, but not that of PI5P4Ks α or β. NIH-12848 could be a potentially powerful tool for exploring the cell physiology of PI5P4Ks[1].

[1]. Clarke JH, et al. The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding site. Biochem J. 2015 Mar 1;466(2):359-67.

مراجعات

Review for NIH-12848

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for NIH-12848

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.